Roche Appeals India High Court Ruling Cipla Drug Not A Tarceva Generic
This article was originally published in PharmAsia News
Executive Summary
Roche has challenged a Delhi High Court judge's decision clearing Cipla of infringing on a patent the Swiss drug maker held for Tarceva (erlotinib), who ruled both the branded drug and its generic, Erlocip, are valid.